We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
all these little 10k plus delayed trades.
The graph shows a flagpole with pennant that's turning into a tightly coiled spring. Breakout is very close and it will be huge.
The lunchtimers will take it up now for an hour
Sizeable seller is ATMs imho
Is this a good thing for LT holders?
Manu it would appear the seller is dumping the delayed trades 9 times out of 10 WINS is picking them up moves down the offer clears them and moves back on the bid, rinse and repeat.
Market price action.
Disagree Manu imho there is a sizeable seller reducing daily direct into the market. probably retail.
MKT PA would indicate that the MMs do not have a overhanging stock.
I agree with the lack of traders affecting the share but I'm not sure whether it's due to the spread, the spread was also huge a few months ago when the Covid play attracted people here, but there was a lot more trades on a daily basis.
I just feel like it's very under the radar here and not many people have realised the potential.
The MMs won’t mark up much while ATM running. The wide spread also puts a lot traders off buying. No quick in and out on this share
Market being soft and Dow futures also doesn’t help
Its becoming ever clearer that the MMs are working a large buy. They tried last week to drag this down with tree hakes but people kept buying. Today has been the same. They thought a tree shake would work but more buyers appeared. This is going to rocket up very quickly soon as the MMs give up or have filled the order.
With all the interest in this company the MMs will work it for all its worth. Like TILS we need patience. Bad pun.
Two very good recent RNSs have now had very little impact on the SP, at the minute it just seems that no matter what news we release, the SP will not move... Why ? There's something that we don't know surely ?
I suppose looking at this realistically, the price maybe stuck because the only drug trialed on Actual patients is milciclib, the others were given to healthy patients which granted showed no toxicity , so I think the explosion will be positive updates on trial progress in ill patients .
There is of course StemprintER which news I’m sure is imminent.
Link?
Some press attention!!
Stocks To Watch in the Daily Mail
Biotechnology minnow Tiziana Life Sciences has signed a deal to ramp up manufacturing of a potential treatment for Covid-19 patients.
Tiziana shot 7 per cent or 7p, to 107p after agreeing with US group STC Biologics to make its antibody, which it believes can help reduce inflammation and prevent serious lung damage, for clinical studies.
The group is working with another firm to develop a technology that will send the drug directly into the lungs using a handheld inhaler.